Nucleoside analogs in the treatment of neoplastic and nonneoplastic diseases
- PMID: 1059360
- DOI: 10.1111/j.1749-6632.1975.tb29234.x
Nucleoside analogs in the treatment of neoplastic and nonneoplastic diseases
Similar articles
-
Purine and pyrimidine nucleoside analogs.Cancer Chemother Biol Response Modif. 2001;19:21-45. Cancer Chemother Biol Response Modif. 2001. PMID: 11686015 Review. No abstract available.
-
Purine analogs and related nucleosides and nucleotides as antitumor agents.Med Res Rev. 1985 Jul-Sep;5(3):273-96. doi: 10.1002/med.2610050302. Med Res Rev. 1985. PMID: 3894832 Review. No abstract available.
-
Basis for clinical resistance to antitumor nucleoside analogs.Ann N Y Acad Sci. 1975 Aug 8;255:235-43. doi: 10.1111/j.1749-6632.1975.tb29229.x. Ann N Y Acad Sci. 1975. PMID: 1103683 Review. No abstract available.
-
[Nucleosides in the chemotherapy of viral infections].Antibiot Khimioter. 1988 May;33(5):386-94. Antibiot Khimioter. 1988. PMID: 3046533 Review. Russian. No abstract available.
-
New nucleoside analogs in the treatment of hematological disorders.Acta Pol Pharm. 2004 May-Jun;61(3):223-32. Acta Pol Pharm. 2004. PMID: 15481249 Review.
Cited by
-
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.BMC Cancer. 2009 Feb 20;9:63. doi: 10.1186/1471-2407-9-63. BMC Cancer. 2009. PMID: 19232100 Free PMC article.
-
Protein kinase C: an attractive target for cancer therapy.Cancers (Basel). 2011 Feb 1;3(1):531-67. doi: 10.3390/cancers3010531. Cancers (Basel). 2011. PMID: 24212628 Free PMC article.
-
Engineering and Preclinical Evaluation of Western Reserve Oncolytic Vaccinia Virus Expressing A167Y Mutant Herpes Simplex Virus Thymidine Kinase.Biomedicines. 2020 Oct 16;8(10):426. doi: 10.3390/biomedicines8100426. Biomedicines. 2020. PMID: 33081279 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources